Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

Medically reviewed by Sanja Jelic, MD Chronic obstructive pulmonary disease (COPD) symptoms can vary from day to day, but a sudden or noticeable change in breathing, mucus, or the frequency of inhaler ...

In recent years, research has revealed more about the factors underlying the pathogenesis of chronic obstructive pulmonary disease (COPD). In particular, inflammation in the lungs leads to the ...

Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with chronic ...

Grace Anne Dorney Koppel, wife of Ted, the longtime anchor of ABC News' Nightline, has been bringing more awareness to COPD, which she was diagnosed with in 2001.

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state. Understanding this variation could help address public health gaps to ease the burden ...

Could mobile technology help patients with chronic obstructive pulmonary disease (COPD) who may not seek care until they experience an exacerbation? A recent study found a wearable device and mobile ...

Researchers report that as many as 70% of people with chronic obstructive pulmonary disease (COPD) or asthma could be undiagnosed. They say that receiving a diagnosis and treatment can dramatically ...

Higher diet quality is associated with better lung function (LF), especially among individuals with asthma or chronic ...

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -- dupilumab -- that showed rapid and sustained improvements in patients in a pivotal Phase 3 ...

Credit: Getty Images Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the classic male presentation. Despite decades of advances in ...

GSK is pleased to announce that Nucala (mepolizumab) has received a positive reimbursement recommendation with conditions from Canada's Drug Agency (CDA-AMC). The agency recommends that Nucala be ...